Fiche de révision : Neuroanatomy and Disease Fundamentals

📋 Course Outline

1. Nervous System Structure
2. Neurons and Glial Cells
3. Stroke Types and Risk Factors
4. Seizure Classifications
5. Multiple Sclerosis Pathology
6. Parkinson’s Disease Features
7. Alzheimer’s Disease Pathology
8. Peripheral Neuropathy Causes
9. Guillain-Barré Syndrome
10. Autism Spectrum Disorder
11. ADHD Symptoms and Treatment
12. Neurodegenerative Diseases

📖 1. Nervous System Structure

🔑 Key Concepts & Definitions

• Nervous System: A complex network of neurons and supporting cells that transmits signals throughout the body, coordinating actions and sensory information.

• Central Nervous System (CNS): Comprises the brain and spinal cord; responsible for processing and integrating information.

• Peripheral Nervous System (PNS): Consists of all nerves outside the CNS; connects the CNS to limbs, organs, and tissues, facilitating communication.

• Neurons: Specialized nerve cells that transmit electrical and chemical signals; the fundamental units of the nervous system.

• Glial Cells: Supportive cells in the nervous system that provide insulation (myelin), nutrients, and structural support to neurons.

• Myelin Sheath: A fatty layer surrounding axons of many neurons, increasing the speed of electrical signal transmission.

📝 Essential Points

• The nervous system is divided into CNS and PNS, with the CNS acting as the control center and the PNS serving as communication lines.

• Neurons communicate via electrical impulses (action potentials) and chemical signals (neurotransmitters).

• Glial cells include astrocytes, oligodendrocytes, Schwann cells, and microglia, each supporting different functions such as myelination and immune defense.

• The brain's major regions include the cerebrum, cerebellum, and brainstem, each with specialized functions.

• The spinal cord transmits signals between the brain and the body and contains neural circuits for reflexes.

💡 Key Takeaway

The nervous system's structure, consisting of the CNS and PNS, with neurons and glial cells as its core components, underpins its ability to process information, coordinate responses, and maintain homeostasis.

📖 2. Neurons and Glial Cells

🔑 Key Concepts & Definitions

• Neuron: The basic functional unit of the nervous system, specialized for transmitting electrical signals via action potentials and synapses.
• Glial Cells: Supportive cells in the nervous system that maintain homeostasis, form myelin, and provide structural and metabolic support to neurons.
• Dendrites: Branched extensions of a neuron that receive electrical signals from other neurons.
• Axon: A long, slender projection that conducts electrical impulses away from the neuron's cell body toward other neurons or effectors.
• Myelin Sheath: A fatty layer produced by oligodendrocytes in the CNS and Schwann cells in the PNS that insulates axons, increasing conduction velocity.
• Synapse: The junction between two neurons where neurotransmitters are released to transmit signals across the synaptic cleft.

📝 Essential Points

• Neurons are polarized cells with distinct structures (dendrites, soma, axon) that facilitate directional signal transmission.
• Glial cells outnumber neurons and perform vital functions such as myelination (oligodendrocytes in CNS, Schwann cells in PNS), immune response (microglia), and metabolic support (astrocytes).
• The integrity of the myelin sheath is crucial for rapid and efficient nerve conduction; demyelination leads to neurological deficits, as seen in multiple sclerosis.
• Synaptic transmission involves neurotransmitter release from the presynaptic neuron and receptor activation on the postsynaptic neuron, enabling communication within neural circuits.
• Damage or dysfunction of neurons or glial cells underpins many neurological disorders, including multiple sclerosis, neuropathies, and neurodegenerative diseases.

💡 Key Takeaway

Neurons are the primary signaling units of the nervous system, while glial cells provide essential support functions; their interaction is fundamental to nervous system health and function.

📖 3. Stroke Types and Risk Factors

🔑 Key Concepts & Definitions

• Stroke: A neurological event caused by interruption of blood flow to the brain, leading to neuronal injury or death.
• Ischemic Stroke: A type of stroke resulting from a blockage (thrombosis or embolism) in a cerebral artery, accounting for approximately 87% of strokes.
• Hemorrhagic Stroke: A stroke caused by bleeding into brain tissue due to rupture of a blood vessel, often associated with hypertension.
• Transient Ischemic Attack (TIA): A temporary blockage of blood flow to the brain that resolves within 24 hours without permanent damage; often a warning sign for future strokes.
• Risk Factors: Conditions or behaviors increasing stroke likelihood, including hypertension, diabetes, smoking, atrial fibrillation, and obesity.

📝 Essential Points

• Types of Stroke are primarily ischemic and hemorrhagic, distinguished by cause and pathology.
• Ischemic strokes are more common and can be caused by thrombi or emboli; treatment includes thrombolytics like tPA if within the therapeutic window.
• Hemorrhagic strokes involve bleeding, often requiring surgical intervention and blood pressure management.
• Risk factors such as hypertension, atrial fibrillation, and diabetes significantly increase stroke risk; controlling these factors reduces incidence.
• TIA serves as a critical warning sign; prompt evaluation and management can prevent full-blown stroke.
• Prevention involves lifestyle modifications, managing blood pressure, anticoagulation in atrial fibrillation, and controlling blood sugar.

💡 Key Takeaway

Understanding the different types of strokes and their risk factors is essential for prevention, early diagnosis, and appropriate treatment to reduce morbidity and mortality.

📖 4. Seizure Classifications

🔑 Key Concepts & Definitions

• Seizure: A sudden, uncontrolled electrical disturbance in the brain causing changes in behavior, sensation, or consciousness.
• Focal Seizure (Partial Seizure): Seizure originating in one specific area of the brain, affecting localized functions.
• Generalized Seizure: Seizure involving both hemispheres of the brain from the onset, leading to widespread effects.
• Simple Focal Seizure: A focal seizure without loss of consciousness; symptoms depend on the affected brain area.
• Complex Focal Seizure: A focal seizure with impaired consciousness or awareness, often with automatisms.
• Secondary Generalization: A focal seizure that evolves into a generalized seizure, affecting both hemispheres.

📝 Essential Points

• Seizures are classified into focal, generalized, and unknown onset based on clinical features and EEG findings.
• Focal seizures can be further divided into simple (preserving consciousness) and complex (impairing consciousness).
• Generalized seizures include types such as tonic-clonic, absence, myoclonic, and atonic seizures.
• The type of seizure influences treatment choices and prognosis.
• EEG is a key diagnostic tool to determine seizure classification.
• Recognizing seizure types is critical for appropriate management and patient safety.

💡 Key Takeaway

Seizure classifications are essential for accurate diagnosis and tailored treatment, with focal and generalized seizures representing the primary categories based on origin and clinical presentation.

📖 5. Multiple Sclerosis Pathology

🔑 Key Concepts & Definitions

• Multiple Sclerosis (MS): An autoimmune, demyelinating disorder of the central nervous system characterized by immune-mediated destruction of myelin sheaths surrounding neurons, leading to impaired nerve conduction.

• Demyelination: Loss or damage of the myelin sheath insulating nerve fibers, resulting in slowed or blocked electrical impulses along neurons.

• Plaques (Lesions): Discrete areas of demyelination and inflammation in the CNS, often seen as sclerotic patches on histology or MRI.

• Oligodendrocytes: Glial cells responsible for forming and maintaining myelin in the CNS; targeted and damaged in MS.

• Relapsing-Remitting MS (RRMS): The most common MS form, characterized by episodes of neurological symptoms (relapses) followed by periods of partial or complete recovery (remissions).

• Axonal Damage: Progressive injury to nerve fibers that can occur secondary to demyelination, contributing to irreversible neurological deficits.

📝 Essential Points

• Pathophysiology: MS involves an autoimmune attack where T cells, B cells, and macrophages target CNS myelin, leading to inflammation, demyelination, and gliosis. The immune response is often triggered by environmental factors in genetically susceptible individuals.

• Histology & Imaging: Characterized by well-demarcated plaques of demyelination, often with perivascular lymphocytic infiltration. MRI is the gold standard for detecting active and chronic lesions.

• Clinical Manifestations: Variable depending on lesion location; common symptoms include visual disturbances (optic neuritis), weakness, sensory deficits, ataxia, and bladder dysfunction.

• Disease Course: Typically starts in young adults, with RRMS being most common. Over time, many patients develop secondary progressive MS with continuous neurological decline.

• Treatment: Disease-modifying therapies (DMTs) such as interferon beta, glatiramer acetate, and newer agents aim to reduce relapse frequency and slow progression. Symptomatic management includes corticosteroids for acute relapses and physical therapy.

• Prognosis: Highly variable; early diagnosis and treatment improve long-term outcomes. Progressive disability can develop over decades.

💡 Key Takeaway

Multiple sclerosis is an autoimmune demyelinating disorder of the CNS marked by episodic inflammation and plaque formation, leading to neurological deficits; early diagnosis and disease-modifying treatments are crucial for managing progression.

📖 6. Parkinson’s Disease Features

🔑 Key Concepts & Definitions

• Parkinson’s Disease (PD): A progressive neurodegenerative disorder characterized primarily by motor symptoms due to loss of dopaminergic neurons in the substantia nigra pars compacta.

• Dopamine: A neurotransmitter involved in regulating movement, mood, and reward pathways; deficits in dopamine are central to PD pathology.

• Bradykinesia: Slowness of movement, a core feature of PD, often leading to difficulty initiating and executing voluntary movements.

• Resting Tremor: Involuntary, rhythmic shaking that occurs when muscles are at rest, commonly presenting as a "pill-rolling" tremor in PD.

• Rigidity: Increased muscle tone causing resistance to passive movement, often described as "cogwheel" rigidity in PD.

• Postural Instability: Impaired balance and coordination, leading to a higher risk of falls in advanced PD.

📝 Essential Points

• Pathophysiology: Degeneration of dopaminergic neurons in the substantia nigra leads to decreased dopamine in the striatum, disrupting the basal ganglia circuitry responsible for smooth movement.

• Motor Symptoms: Classic features include resting tremor, bradykinesia, rigidity, and postural instability. These symptoms often appear asymmetrically initially.

• Non-Motor Symptoms: Include autonomic dysfunction (e.g., orthostatic hypotension), sleep disturbances, depression, and cognitive impairment, especially in later stages.

• Diagnosis: Primarily clinical, based on the presence of cardinal motor features. Response to dopaminergic therapy (e.g., levodopa) supports diagnosis.

• Treatment: Mainstay is pharmacotherapy with levodopa/carbidopa, dopamine agonists, MAO-B inhibitors, and COMT inhibitors. Deep brain stimulation (DBS) may be indicated in advanced cases.

• Progression & Management: Disease progression leads to motor fluctuations and dyskinesias. Multidisciplinary management includes medication, physical therapy, and supportive care.

💡 Key Takeaway

Parkinson’s Disease is a neurodegenerative disorder marked by dopamine deficiency in the basal ganglia, leading to characteristic motor and non-motor symptoms; early diagnosis and treatment with dopaminergic agents are essential for symptom management and improving quality of life.

📖 7. Alzheimer’s Disease Pathology

🔑 Key Concepts & Definitions

• Amyloid Plaques: Extracellular deposits primarily composed of beta-amyloid peptides that accumulate between neurons, disrupting cell function.
• Neurofibrillary Tangles: Intracellular aggregates of hyperphosphorylated tau protein that form twisted fibers within neurons, leading to cell death.
• Beta-Amyloid Peptides: Fragments derived from amyloid precursor protein (APP) that tend to aggregate and form plaques in Alzheimer’s disease.
• Cholinergic Neurodegeneration: Loss of cholinergic neurons, especially in the basal forebrain, contributing to cognitive decline.
• Hippocampal Atrophy: Shrinkage of the hippocampus, a key brain region involved in memory formation, characteristic of Alzheimer’s pathology.

📝 Essential Points

• Alzheimer’s disease is characterized by the presence of amyloid plaques and neurofibrillary tangles, leading to progressive neuronal loss.
• The accumulation of beta-amyloid peptides results from abnormal processing of APP, often due to genetic mutations or age-related changes.
• Tau protein becomes hyperphosphorylated, losing its ability to stabilize microtubules, which promotes tangle formation.
• Early symptoms include memory impairment, especially in the hippocampus, progressing to language, visuospatial, and executive dysfunction.
• Pathological changes are most prominent in the hippocampus, entorhinal cortex, and association cortices.
• The disease involves cholinergic deficits, which are targeted by symptomatic treatments like cholinesterase inhibitors.
• Genetic factors: mutations in APP, PSEN1, and PSEN2 genes increase risk; APOE ε4 allele is a major genetic risk factor.
• No definitive cure exists; current treatments aim to slow progression and manage symptoms.

💡 Key Takeaway

Alzheimer’s disease pathology centers on the accumulation of beta-amyloid plaques and tau neurofibrillary tangles, leading to neuronal death, especially in memory-related brain regions, resulting in progressive cognitive decline.

📖 8. Peripheral Neuropathy Causes

🔑 Key Concepts & Definitions

• Peripheral Neuropathy: A disorder resulting from damage to the peripheral nerves, causing weakness, numbness, and pain, typically in the hands and feet.

• Diabetic Neuropathy: A common form of peripheral neuropathy caused by chronic high blood sugar levels damaging nerve fibers, especially in diabetic patients.

• Toxic Neuropathy: Nerve damage caused by exposure to toxins such as alcohol, heavy metals (lead, mercury), or certain medications (e.g., chemotherapy agents).

• Nutritional Deficiencies: Lack of essential nutrients like vitamin B12, folate, or vitamin E can impair nerve function, leading to neuropathy.

• Autoimmune Neuropathy: Nerve damage resulting from immune system attacks on peripheral nerves, as seen in conditions like Guillain-Barré syndrome.

• Infectious Causes: Certain infections (e.g., HIV, Lyme disease, leprosy) can directly infect or trigger immune responses damaging peripheral nerves.

📝 Essential Points

• Causes are diverse: including metabolic (diabetes), toxic, nutritional, infectious, autoimmune, hereditary, and traumatic factors.

• Pathophysiology varies: nerve damage can be axonal (affecting the nerve fiber itself) or demyelinating (affecting the nerve's myelin sheath).

• Common risk factors: chronic illnesses (especially diabetes), exposure to neurotoxins, nutritional deficiencies, and infections.

• Clinical relevance: identifying the cause is crucial for targeted treatment and prognosis; for example, correcting vitamin deficiencies or removing toxins.

• Genetic causes: hereditary conditions like Charcot-Marie-Tooth disease also contribute to peripheral neuropathy.

💡 Key Takeaway

Peripheral neuropathy results from a wide range of causes, with metabolic, toxic, nutritional, infectious, and autoimmune factors playing major roles; accurate diagnosis hinges on identifying these underlying causes for effective management.

📖 9. Guillain-Barré Syndrome

🔑 Key Concepts & Definitions

• Guillain-Barré Syndrome (GBS): An acute autoimmune disorder where the body's immune system attacks peripheral nerves, leading to rapid-onset muscle weakness and paralysis.

• Demyelination: The destruction of the myelin sheath surrounding peripheral nerves, impairing nerve conduction and resulting in weakness and sensory disturbances.

• Areflexia: Loss of reflexes, a hallmark feature of GBS, due to nerve conduction failure.

• Ascending Paralysis: Progressive muscle weakness starting in the lower limbs and moving upward, characteristic of GBS.

• Campylobacter jejuni: A common antecedent infection (often gastrointestinal) linked to the development of GBS, thought to trigger autoimmune response via molecular mimicry.

• Plasmapheresis & Intravenous Immunoglobulin (IVIG): Main treatments that modulate the immune response, reducing nerve damage and improving recovery.

📝 Essential Points

• Etiology & Pathogenesis: Usually follows infections (e.g., Campylobacter, CMV). The immune system mistakenly targets peripheral nerve myelin or axons due to molecular mimicry.

• Clinical Presentation: Rapidly progressing ascending weakness, areflexia, sensory disturbances, and possible autonomic dysfunction (e.g., arrhythmias, blood pressure fluctuations).

• Diagnosis:

  • Clinical features: Symmetric weakness, areflexia.
  • Lumbar puncture: Elevated protein with normal cell count (albuminocytologic dissociation).
  • Nerve conduction studies: Demyelination features such as slowed conduction velocity.

• Prognosis & Complications:

  • Most patients recover with supportive care.
  • Potential complications include respiratory failure requiring mechanical ventilation, autonomic instability, and deep vein thrombosis.

• Management:

  • Hospitalization for close monitoring.
  • Immunotherapy (IVIG or plasmapheresis).
  • Supportive care: Respiratory support, physical therapy.

💡 Key Takeaway

Guillain-Barré Syndrome is an acute autoimmune peripheral neuropathy characterized by ascending paralysis and areflexia, often triggered by infection; prompt immunotherapy and supportive care are crucial for recovery.

📖 10. Autism Spectrum Disorder

🔑 Key Concepts & Definitions

• Autism Spectrum Disorder (ASD): A neurodevelopmental condition characterized by persistent deficits in social communication and interaction, along with restricted, repetitive patterns of behavior, interests, or activities. It varies widely in severity and presentation.

• Social Communication Deficits: Difficulties in social reciprocity, nonverbal communicative behaviors, and developing, maintaining, and understanding relationships.

• Repetitive Behaviors and Restricted Interests: Stereotyped movements, insistence on sameness, highly restricted interests, and hyper- or hypo-reactivity to sensory input.

• Neurodevelopmental Disorder: A group of conditions originating in the developmental period that cause impairments in personal, social, academic, or occupational functioning.

• Etiology: The exact cause of ASD is unknown; however, genetic factors, environmental influences, and neurobiological differences are implicated.

• Comorbidities: Frequently associated with intellectual disability, language impairment, ADHD, anxiety, and epilepsy.

📝 Essential Points

• Diagnosis: Based on behavioral criteria outlined in DSM-5; no definitive biomarker exists. Early diagnosis and intervention improve outcomes.

• Onset: Symptoms typically appear in the first two years of life, with signs including lack of eye contact, delayed speech, and limited social engagement.

• Neurobiological Basis: Abnormalities in brain connectivity, synaptic function, and neurotransmitter systems (e.g., serotonin, GABA) are observed, but no single cause has been identified.

• Interventions: Behavioral therapies (e.g., Applied Behavior Analysis), speech and occupational therapy, and educational support are mainstays. Pharmacotherapy may address associated symptoms like irritability or hyperactivity.

• Prognosis: Varies; some individuals achieve independence with support, while others require lifelong assistance. Early intervention is crucial for better developmental outcomes.

• Epidemiology: Prevalence is approximately 1 in 44 children in the U.S., with a higher male-to-female ratio (~4:1).

💡 Key Takeaway

Autism Spectrum Disorder is a complex neurodevelopmental condition marked by diverse behavioral symptoms and severity, with early diagnosis and tailored interventions being essential for optimizing individual outcomes.

📖 11. ADHD Symptoms and Treatment

🔑 Key Concepts & Definitions

• Attention Deficit Hyperactivity Disorder (ADHD): A neurodevelopmental disorder characterized by persistent patterns of inattention, hyperactivity, and impulsivity that interfere with functioning or development.

• Inattention: Difficulty sustaining focus, careless mistakes, forgetfulness, and disorganization.

• Hyperactivity: Excessive movement, fidgeting, difficulty remaining seated, and an inability to stay still.

• Impulsivity: Acting without forethought, interrupting others, difficulty delaying gratification, and poor impulse control.

• Neurochemical Basis: Dysfunction in dopamine and norepinephrine pathways in the brain, affecting attention and impulse regulation.

• Treatment Modalities: Pharmacological (stimulants and non-stimulants), behavioral therapy, and educational interventions.

📝 Essential Points

• ADHD is most commonly diagnosed in children but can persist into adulthood.
• Core symptoms are divided into two categories: inattentive and hyperactive-impulsive; individuals may exhibit one or both.
• Diagnostic criteria require symptoms to be present before age 12 and to impair social, academic, or occupational functioning.
• Stimulant medications (e.g., methylphenidate, amphetamines) are first-line treatments; non-stimulants (e.g., atomoxetine) are alternatives.
• Behavioral interventions include parent training, cognitive-behavioral therapy, and classroom accommodations.
• Comorbidities such as learning disabilities, anxiety, and oppositional defiant disorder are common.

💡 Key Takeaway

ADHD is a neurodevelopmental disorder marked by inattention, hyperactivity, and impulsivity, primarily managed through stimulant medications and behavioral strategies to improve functioning and quality of life.

📖 12. Neurodegenerative Diseases

🔑 Key Concepts & Definitions

• Neurodegeneration: Progressive loss of structure or function of neurons, leading to neuronal death, characteristic of diseases like Alzheimer’s and Parkinson’s.

• Amyloid Plaques: Extracellular deposits primarily composed of beta-amyloid peptides found in the brains of Alzheimer’s patients, associated with neurodegeneration.

• Tau Tangles: Abnormally phosphorylated tau proteins forming neurofibrillary tangles inside neurons, contributing to Alzheimer’s pathology.

• Dopaminergic Neurons: Neurons that produce dopamine, primarily affected in Parkinson’s disease, leading to motor symptoms.

• Genetic Factors: Inherited mutations or genetic predispositions that increase the risk of neurodegenerative diseases, such as mutations in APP, PSEN1, PSEN2 for Alzheimer’s, or SNCA for Parkinson’s.

• Neuroinflammation: Activation of immune responses within the nervous system, contributing to neuronal damage in neurodegenerative conditions.

📝 Essential Points

• Neurodegenerative diseases are characterized by progressive neuronal loss, leading to cognitive, motor, or behavioral deficits.

• Alzheimer’s Disease is marked by amyloid plaques and tau tangles, resulting in memory loss and cognitive decline.

• Parkinson’s Disease involves the degeneration of dopaminergic neurons in the substantia nigra, causing tremors, rigidity, and bradykinesia.

• Genetic mutations play a significant role in early-onset cases, while environmental factors contribute to sporadic forms.

• Pathological features often include abnormal protein aggregations, neuroinflammation, and oxidative stress.

• Currently, most treatments are symptomatic; no cure exists, but research aims at disease-modifying therapies.

• Early diagnosis is crucial for management and slowing disease progression.

💡 Key Takeaway

Neurodegenerative diseases involve complex pathological processes like protein aggregation and neuronal loss, with genetics and environment influencing disease onset; understanding these mechanisms is vital for developing effective treatments.

📊 Synthesis Tables

⚠️ Common Pitfalls & Confusions

1. Confusing CNS and PNS functions; CNS processes info, PNS transmits signals.
2. Misidentifying stroke types; ischemic vs hemorrhagic based on imaging and cause.
3. Overlooking the distinction between focal and generalized seizures; clinical features and EEG help differentiate.
4. Assuming all demyelinating diseases are MS; other causes include neuromyelitis optica.
5. Confusing Parkinson’s disease features with other movement disorders like essential tremor.
6. Misinterpreting Alzheimer’s pathology; amyloid plaques and neurofibrillary tangles are hallmark features.
7. Overgeneralizing peripheral neuropathy causes; consider diabetes, toxins, infections.
8. Mistaking Guillain-Barré syndrome for other motor neuropathies; rapid progression and areflexia are key.
9. Overlooking the spectrum of autism; symptoms vary widely, affecting social, communication, and behavior.
10. Confusing ADHD symptoms with other behavioral or mood disorders; focus on inattention, hyperactivity, impulsivity.
11. Assuming all neurodegenerative diseases are treatable; many are progressive with limited therapies.
12. Ignoring the importance of early detection and management in stroke, MS, and seizure disorders.

✅ Exam Checklist

• Describe the basic structure and components of the nervous system.
• Differentiate between neurons and glial cells and their functions.
• Identify the main types of stroke and their risk factors.
• Classify seizures into focal and generalized, noting clinical features.
• Explain the pathology and features of multiple sclerosis.
• Recognize key features and pathology of Parkinson’s disease.
• Summarize Alzheimer’s disease pathology and clinical presentation.
• List common causes of peripheral neuropathy.
• Describe Guillain-Barré syndrome and its typical presentation.
• Outline core features of autism spectrum disorder.
• Identify symptoms and treatment options for ADHD.
• Summarize the pathology and progression of major neurodegenerative diseases.